Australia markets open in 4 hours 57 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.64-0.16 (-0.69%)
As of 01:02PM EST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
397,624
365,978
353,874
306,486
Cost of revenue
5,259
5,281
5,582
5,504
Gross profit
392,365
360,697
348,292
300,982
Operating expenses
Research development
122,756
113,864
114,764
89,017
Selling general and administrative
142,810
122,356
105,326
100,359
Total operating expenses
265,566
236,220
220,090
189,376
Operating income or loss
126,799
124,477
128,202
111,606
Income before tax
128,651
125,006
131,602
116,676
Income tax expense
11,781
12,494
25,591
22,495
Income from continuing operations
116,870
112,512
106,011
94,181
Net income
116,870
112,512
106,011
94,181
Net income available to common shareholders
116,808
112,512
106,011
94,181
Basic EPS
-
0.97
0.92
0.82
Diluted EPS
-
0.89
0.85
0.77
Basic average shares
-
115,653
115,412
114,349
Diluted average shares
-
125,963
124,194
122,566
EBITDA
-
127,544
130,439
113,777